Assessing the Validity of the Omron HEM-907XL Oscillometric Blood Pressure Measurement Device in a National Survey Environment
Assessing the Validity of the Omron HEM-907XL Oscillometric Blood Pressure Measurement Device in a National Survey Environment
复制标题
DOI：
10.1111/j.1751-7176.2009.00199.x
复制
发表时间：
2010-01-01
影响因子：
2.8
通讯作者：
Zipf, George
中科院分区：
文献类型：
--
作者：
Ostchega, Yechiam;Nwankwo, Tatiana;Zipf, George
用欧姆龙HEM-907XL测量的血压（BP）读数与使用血压计（HgS）获得的结果在509个人中进行了比较，使用2002年医疗器械进步协会（AAMI）标准。除了13 - 19岁青少年的舒张压（平均差-1.77 mm Hg，标准差8.65）外，欧姆龙设备符合标准。高血压（BP >= 140/90 mm Hg）的一致性高于概率（kappa=0.68），与HgS相比，欧姆龙低估了2.65%的高血压患病率。Omron和HgS测量高度相关（收缩压r=0.94，舒张压r=0.83）。收缩压和舒张压升高均降低了器械一致性(β系数=-0.10872，P
Blood pressure (BP) readings taken by Omron HEM-907XL were compared with the results obtained using sphygmomanometer (HgS) in 509 individuals using 2002 Association for the Advancement of Medical Instrumentation (AAMI) criteria. With the exception of diastolic BP in youth ages 13 to 19 years (mean difference, -1.77 mm Hg; standard deviation, 8.65), the Omron device met the criteria. Agreement for hypertension (BP >= 140/90 mm Hg) was above chance (kappa=0.68) and, compared with HgS, Omron underestimated the prevalence of hypertension by 2.65%. The Omron and HgS measurements were highly correlated (r=0.94 for systolic BP and r=0.83 for diastolic BP). Both increased systolic and diastolic BP decreased device agreement (beta-coefficient=-0.10872, P